Rite Aid Facing Class Action Claiming It Overcharges for Generic Drugs
Last Updated on May 8, 2018
Stafford v. Rite Aid Corporation
Filed: June 30, 2017 ◆§ 3:17-cv-01340-BEN-JLB
According to a recent class action, Rite Aid runs a deceptive pricing scheme in which it undercuts the 'usual and customary' prices for generic drugs.
Echoing a lawsuit filed against Walgreens back in May, a California consumer alleges in a new proposed class action that Rite Aid Corporation overcharges those enrolled in both private and public healthcare insurance plans for generic prescription drugs. The 42-page lawsuit claims Rite Aid, through its “deceptive and unfair pricing scheme,” submits to third-party healthcare plans copayments that are significantly higher than the nation’s third-largest pharmacy chain’s “usual and customary” costs for generics.
At the heart of Rite Aid’s alleged scheme, the lawsuit claims, is its Rx Savings Program, which allows cash-paying customers, i.e. individuals who purchase drugs without insurance, to buy generics at discounted prices. The lawsuit claims Rite Aid, through its Rx Savings Program, significantly undercuts the “usual and customary” prices for generics it reports to health insurance companies, and, thusly, “the amounts that individuals using insurance must pay for the drugs in the form of a copayment.”
Video Game Addiction Lawsuits
If your child suffers from video game addiction — including Fortnite addiction or Roblox addiction — you may be able to take legal action. Gamers 18 to 22 may also qualify.
Learn more:Video Game Addiction Lawsuit
Depo-Provera Lawsuits
Anyone who received Depo-Provera or Depo-Provera SubQ injections and has been diagnosed with meningioma, a type of brain tumor, may be able to take legal action.
Read more: Depo-Provera Lawsuit
How Do I Join a Class Action Lawsuit?
Did you know there's usually nothing you need to do to join, sign up for, or add your name to new class action lawsuits when they're initially filed?
Read more here: How Do I Join a Class Action Lawsuit?
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.